PhRMA Statement on the President’s Fiscal Year 2013 Budget

Washington, D.C. (February 13, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement on the President’s budget proposal:

“Despite President Obama’s many pronouncements to support innovation, advance biomedical research, promote job creation and control health care costs for seniors, his 2013 budget proposal flies in the face of these important goals.

Key Facts About Prescription Medicine Costs

PhRMA Releases New Data on Biopharmaceutical Industry’s Contributions to Local, State Economies

Washington, D.C. (November 13, 2012) — Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released new data highlighting the biopharmaceutical industry’s vital role in contributing to the U.S. economy. The data represent approximately $53 billion across 17 states, spent with businesses that provide important services and supplies in support of the industry’s mission to bring new medicines to patients.

PhRMA Principles on Interactions with Patient Organizations

PhRMA Statement on Prescription Drug Costs

Washington, D.C. (August 2, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today:

PhRMA Statement on SCOTUS Ruling

Washington, D.C. (June 28, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement today:

Growth Platform For Economies Around the World

Medicare Part D At Age Five: What has Happened to Seniors' Prescription Drug Prices

PhRMA Statement Supporting U.S. Economic Recovery Advisers

Washington, D.C. (Jan. 21, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today regarding the President’s new economic recovery advisory board:

“PhRMA commends President Obama for establishing a new Council on Jobs and Competitiveness, to be led by General Electric Chief Executive Officer Jeffrey R. Immelt.

Improving Prescription Medicine Adherence

Pages

Subscribe to RSS - Value